The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics
Open accessAbstract
BACKGROUND: Endometriosis, the growth of endometrial tissue outside the uterine cavity, is associated with chronic pelvic pain, subfertility and an increased risk of ovarian cancer. Current treatments include the surgical removal of the lesions or the induction of a hypoestrogenic state. However, a reappearance of the lesion after surgery is common and a hypoestrogenic state is less than optimal for women of reproductive age. Additional approaches are required. Endometriosis lesions exist in a unique microenvironment characterized by increased concentrations of hormones, inflammation, oxidative stress and iron. This environment influences cell survival through the binding of membrane receptors and a subsequent cascading activation of intracellular kinases that stimulate a cellular response. Many of these kinase signalling pathways are constitutively activated in endometriosis. These pathways are being investigated as therapeutic targets in other diseases and thus may also represent a target for endometriosis treatment. METHODS: To identify relevant English language studies published up to 2015 on kinase signalling pathways in endometriosis, we searched the Pubmed database using the following search terms in various combinations; 'endometriosis', 'inflammation', 'oxidative stress', 'iron', 'kinase', 'NF kappa', 'mTOR', 'MAPK' 'p38', 'JNK', 'ERK' 'estrogen' and progesterone'. Further citing references were identified using the Scopus database and finally current clinical trials were searched on the clinicaltrials.gov trial registry. RESULTS: The current literature on intracellular kinases activated by the endometriotic environment can be summarized into three main pathways that could be targeted for treatments: the canonical IKKβ/NFκB pathway, the MAPK pathways (ERK1/2, p38 and JNK) and the PI3K/AKT/mTOR pathway. A number of pharmaceutical compounds that target these pathways have been successfully trialled in in vitro and animal models of endometriosis, although they have not yet proceeded to clinical trials. The current generation of kinase inhibitors carry a potential for adverse side effects. CONCLUSIONS: Kinase signalling pathways represent viable targets for endometriosis treatment. At present, however, further improvements in clinical efficacy and the profile of adverse effects are required before these compounds can be useful for long-term endometriosis treatment. A better understanding of the molecular activity of these kinases, including the specific extracellular compounds that lead to their activation in endometriotic cells specifically should facilitate their improvement and could potentially lead to new, non-hormonal treatments of endometriosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 2×
“, 1995) activates 5′ adenosine monophosphate-activated protein kinase (AMPK), mediating the drug’s effects in muscle, adipose, liver (Zhou et al., 2001) and breast cancer cells (Zakikhani et al.”
BackgroundThe phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621 · cited 1×
“Proteins with a pleckstrin homology domain, such as phosphoinositidedependent kinase 1 (PDK1) and AKT are co-recruited to PIP3 and their subsequent proximity results in AKT phosphorylation by PDK1 (Cantley, 2002).”
BackgroundTSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 1×
“The canonical NFkB pathway is characterized by activity of the IKKb catalytic subunit removing IkB from p65 and targeting it for ubiquitin ligase-mediated degradation (Ghosh and Karin, 2002).”
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558 · cited 2×
“SP600125 is a small molecular weight inhibitor developed to specifically target JNK (Bennett et al., 2001) and initial studies in both mouse models and in in vitro analysis of human synoviocytes, as a model of rheumatoid arthritis, it was capable of reducing the inflammatory response (Han et al.”
BackgroundThe two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954 · cited 2×
“The upstream mediator of the MAPK pathways, Ras-GTP, can bind and activate PI3K (Rodriguez-Viciana et al., 1994) and an ERK mediated phosphorylation of TSC2 also occurs (Roux et al., 2004).”
BackgroundCrosstalk in NF-κB Signaling Pathways
Oeckinghaus, A., Hayden, M. S., & Ghosh, S. (2011) · Nature Immunology · doi:10.1038/ni.2065 · Cited by 1,942
Pathogenesis and pathophysiology of endometriosis
Burney, R. O., & Giudice, L. C. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.029 · Cited by 1,590
Termination of autophagy and reformation of lysosomes regulated by mTOR
Yu, L., McPhee, C. K., Zheng, L., Mardones, G. A., Rong, Y., Peng, J., Mi, N., Zhao, Y., Liu, Z., Wan, F., et al. (2010) · Nature · doi:10.1038/nature09076 · Cited by 1,544 · cited 1×
“If nutrients and growth factors are withdrawn or oxidative stress occurs, inhibition of mTOR allows autophagic process to increase, resulting in the production of amino acids that function as a feedback loop to again activate mTOR and attenuate the autophagic response (Yu et al., 2010).”
BackgroundNisolle, M., & Donnez, J. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00191-x · Cited by 1,279
Hayden, M. S., West, A. P., & Ghosh, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209943 · Cited by 1,178 · cited 1×
“The NFkB pathway in endometriosis NFkB is the nodal point of a primary inflammation stimulated signalling pathway that has a significant role in the immune response (Hayden et al., 2006).”
BackgroundMetabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148 · cited 2×
“Metformin, an oral anti-diabetic drug (Stumvoll et al., 1995) activates 5′ adenosine monophosphate-activated protein kinase (AMPK), mediating the drug’s effects in muscle, adipose, liver (Zhou et al.”
BackgroundSimoens, S., Dunselman, G., Dirksen, C., Hummelshoj, L., Bokor, A., Brandes, I., Brodszky, V., Canis, M., Colombo, G. L., DeLeire, T., et al. (2012) · Human Reproduction · doi:10.1093/humrep/des073 · Cited by 1,070
Self-citationMetformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Targeting Multiple Signaling Pathways by Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate
Khan, N., Afaq, F., Saleem, M., Ahmad, N., & Mukhtar, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3636 · Cited by 820
Morris, E. J., Jha, S., Restaino, C. R., Dayananth, P., Zhu, H., Cooper, A., Carr, D., Deng, Y., Jin, W., Black, S., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0070 · Cited by 676 · cited 2×
“…alleviates clinical arthritis and hypersensitivity elicited by an inflammatory reaction in collagen induced arthritis in a DBA/1 mouse model (Ohori et al., 2007) and SCH772984 has been successful in preclinical testing in cell lines that were BRAF and MEK inhibitor-resistant (Morris et al., 2013).”
BackgroundHigh prevalence of endometriosis in infertile women with normal ovulation and normospermic partners
Meuleman, C., Vandenabeele, B., Fieuws, S., Spiessens, C., Timmerman, D., & D'Hooghe, T. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.04.056 · Cited by 606
Aromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 2×
“through endometrial cell expression of aromatase p450 (Noble et al., 1996) and a reduction in 17b-hydroxysteroid dehydrogenase type II”
BackgroundDeep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management
Abrao, M. S., Petraglia, F., Falcone, T., Keckstein, J., Osuga, Y., & Chapron, C. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv003 · Cited by 398
Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis1
Xue, Q., Lin, Z., Cheng, Y.-H., Huang, C.-C., Marsh, E., Yin, P., Milad, M. P., Confino, E., Reierstad, S., Innes, J., et al. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.061804 · Cited by 346 · cited 3×
“Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis.”
BackgroundSurgical treatment of deeply infiltrating endometriosis with colorectal involvement
Meuleman, C., Tomassetti, C., D'Hoore, A., Van Cleynenbreugel, B., Penninckx, F., Vergote, I., & D'Hooghe, T. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq057 · Cited by 338
Yamaguchi, K., Mandai, M., Toyokuni, S., Hamanishi, J., Higuchi, T., Takakura, K., & Fujii, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1614 · Cited by 324 · cited 2×
“…enter the peritoneal cavity via retrograde menstruation resulting in increased iron concentrations (Arumugam and Yip, 1995; Iizuka et al., 1998; Yamaguchi et al., 2008) that accumulate in peritoneal macrophages (Lousse et al., 2009) and mediate oxidative stress (Defrère et al., 2008) in both…”
BackgroundDeep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease
Chapron, C. (2003) · Human Reproduction · doi:10.1093/humrep/deg152 · Cited by 311
The role of microRNAs in endometriosis and associated reproductive conditions
Ohlsson Teague, E. M. C., Print, C. G., & Hull, M. L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp034 · Cited by 309
Zeitoun, K., Takayama, K., Sasano, H., Suzuki, T., Moghrabi, N., Andersson, S., Johns, A., Meng, L., Putman, M., Carr, B., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5301 · Cited by 308 · cited 2×
“, 1996) and a reduction in 17b-hydroxysteroid dehydrogenase type II (Zeitoun et al., 1998).”
BackgroundEndometriosis: an overview of Cochrane Reviews
Brown, J., & Farquhar, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009590.pub2 · Cited by 270 · cited 1×
“Hormonal modulation through medical therapies creates a hypoestrogenic environment with hormonal contraception, progestogens, anti-progestogens, gonadotrophin-releasing hormone analogues and aromatase inhibitors (Brown and Farquhar, 2014).”
BackgroundEstrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis
Bulun, S., Cheng, Y.-H., Pavone, M., Xue, Q., Attar, E., Trukhacheva, E., Tokunaga, H., Utsunomiya, H., Yin, P., Luo, X., et al. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1242991 · Cited by 243 · cited 2×
“, 2009) and possibly of progesterone receptors (PRs) (Bulun et al., 2010).”
BackgroundRahmioglu, N., Nyholt, D. R., Morris, A. P., Missmer, S. A., Montgomery, G. W., & Zondervan, K. T. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu015 · Cited by 238
Potential involvement of iron in the pathogenesis of peritoneal endometriosis
Defrere, S., Lousse, J. C., Gonzalez-Ramos, R., Colette, S., Donnez, J., & Van Langendonckt, A. (2008) · Molecular Human Reproduction · doi:10.1093/molehr/gan033 · Cited by 204 · cited 2×
“(Defrère et al., 2008) in both the peritoneal fluid (Carvalho et al.”
BackgroundPeripheral changes in endometriosis-associated pain
Morotti, M., Vincent, K., Brawn, J., Zondervan, K. T., & Becker, C. M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu021 · Cited by 198
mTOR regulates cellular iron homeostasis through tristetraprolin
Bayeva, M., Khechaduri, A., Puig, S., Chang, H.-C., Patial, S., Blackshear, P. J., & Ardehali, H. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.001 · Cited by 197
Trukhacheva, E., Lin, Z., Reierstad, S., Cheng, Y.-H., Milad, M., & Bulun, S. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1466 · Cited by 143
All Roads Lead to mTOR: Integrating Inflammation and Tumor Angiogenesis
Lee, D.-F., & Hung, M.-C. (2007) · Cell Cycle · doi:10.4161/cc.6.24.5085 · Cited by 115
Somigliana, E. (2004) · Human Reproduction · doi:10.1093/humrep/deg513 · Cited by 115
Sun, H. S., Hsiao, K.-Y., Hsu, C.-C., Wu, M.-H., & Tsai, S.-J. (2003) · Endocrinology · doi:10.1210/en.2003-0289 · Cited by 114 · cited 1×
“The chemokine MCP1 also elicits a significant induction of PGE2 (Carli et al., 2009) as well as VEGF, IL-8 and MCP-1 via an ERKspecific pathway in human endometriotic cells (Veillat et al., 2010), and PGE2 in turn activates ERK in ectopic endometrial stromal cells (Sun et al., 2003).”
BackgroundProtein kinase inhibitors can control the progression of endometriosis in vitro and in vivo
Ngô, C., Nicco, C., Leconte, M., Chéreau, C., Arkwright, S., Vacher‐Lavenu, M., Weill, B., Chapron, C., & Batteux, F. (2010) · The Journal of Pathology · doi:10.1002/path.2756 · Cited by 78
Occult microscopic endometriosis: undetectable by laparoscopy in normal peritoneum
Khan, K. N., Fujishita, A., Kitajima, M., Hiraki, K., Nakashima, M., & Masuzaki, H. (2014) · Human Reproduction · doi:10.1093/humrep/det438 · Cited by 72 · cited 2×
“surgery or to the presence of occult endometriosis (Khan et al., 2014) are possible.”
BackgroundThe inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis
Olivares, C., Ricci, A., Bilotas, M., Barañao, R. I., & Meresman, G. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.063 · Cited by 65
Wu, M., Lin, S., Hsiao, K., & Tsai, S. (2011) · The Journal of Pathology · doi:10.1002/path.2963 · Cited by 65
McKinnon, B. D., Evers, J., Bersinger, N. A., & Mueller, M. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1019 · Cited by 32 · cited 2×
“, 1992) that interact with endometriotic lesions (McKinnon et al., 2013).”
BackgroundSelf-citation
Cited by
Zondervan, K. T., Becker, C. M., Koga, K., Missmer, S. A., Taylor, R. N., & Viganò, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0008-5 · Cited by 1,257
Rethinking mechanisms, diagnosis and management of endometriosis
Chapron, C., Marcellin, L., Borghese, B., & Santulli, P. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0245-z · Cited by 1,084
Endometriosis: Epidemiology, Diagnosis and Clinical Management
Parasar, P., Ozcan, P., & Terry, K. L. (2017) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-017-0187-1 · Cited by 753
What exactly is endometrial receptivity?
Lessey, B. A., & Young, S. L. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.02.009 · Cited by 439
Suda, K., Nakaoka, H., Yoshihara, K., Ishiguro, T., Tamura, R., Mori, Y., Yamawaki, K., Adachi, S., Takahashi, T., Kase, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.037 · Cited by 414
Metadata
- Authors
- McKinnon, B. D., Kocbek, V., Nirgianakis, K., Bersinger, N. A., & Mueller, M. D.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-01-05
- Volume
- 22
- Issue
- 3
- Pages
- 382-403
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2284803191
- Cited by
- 192
- References
- 45
- FWCI
- 20.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.